Brokerages predict that Proto Labs, Inc. (NYSE:PRLB) will report sales of $85.53 million for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Proto Labs’ earnings. The highest sales estimate is $85.99 million and the lowest is $85.30 million. Proto Labs posted sales of $78.17 million in the same quarter last year, which suggests a positive year-over-year growth rate of 9.4%. The company is scheduled to report its next earnings results on Thursday, October 26th.

On average, analysts expect that Proto Labs will report full-year sales of $85.53 million for the current fiscal year, with estimates ranging from $333.89 million to $336.70 million. For the next financial year, analysts anticipate that the business will report sales of $369.60 million per share, with estimates ranging from $366.39 million to $374.31 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research analysts that follow Proto Labs.

Proto Labs (NYSE:PRLB) last released its earnings results on Thursday, July 27th. The industrial products company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.06. Proto Labs had a return on equity of 11.75% and a net margin of 14.59%. The business had revenue of $82.04 million during the quarter, compared to the consensus estimate of $80.49 million. During the same period last year, the company earned $0.45 earnings per share. The business’s revenue for the quarter was up 9.4% compared to the same quarter last year.

Several equities analysts recently issued reports on PRLB shares. Dougherty & Co raised Proto Labs from a “sell” rating to a “neutral” rating in a research note on Tuesday, June 27th. Zacks Investment Research lowered Proto Labs from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, June 28th. Finally, Piper Jaffray Companies reissued a “hold” rating and set a $67.00 target price on shares of Proto Labs in a research note on Friday, July 28th. Four investment analysts have rated the stock with a hold rating, Proto Labs currently has an average rating of “Hold” and a consensus target price of $59.33.

Shares of Proto Labs (PRLB) opened at 74.20 on Friday. The company has a market capitalization of $1.97 billion, a P/E ratio of 43.14 and a beta of 0.99. Proto Labs has a 52-week low of $43.10 and a 52-week high of $75.80. The stock’s 50 day moving average price is $72.42 and its 200 day moving average price is $63.04.

WARNING: “$85.53 Million in Sales Expected for Proto Labs, Inc. (PRLB) This Quarter” was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/09/15/85-53-million-in-sales-expected-for-proto-labs-inc-prlb-this-quarter.html.

In other Proto Labs news, VP Robert Bodor sold 741 shares of the stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $73.84, for a total value of $54,715.44. Following the sale, the vice president now owns 17,319 shares of the company’s stock, valued at approximately $1,278,834.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 7.78% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently added to or reduced their stakes in PRLB. Teachers Advisors LLC increased its holdings in shares of Proto Labs by 1.8% in the 4th quarter. Teachers Advisors LLC now owns 43,284 shares of the industrial products company’s stock valued at $2,223,000 after acquiring an additional 755 shares during the last quarter. Louisiana State Employees Retirement System increased its holdings in shares of Proto Labs by 1.0% in the 1st quarter. Louisiana State Employees Retirement System now owns 9,900 shares of the industrial products company’s stock valued at $506,000 after acquiring an additional 100 shares during the last quarter. Great West Life Assurance Co. Can increased its holdings in shares of Proto Labs by 8.7% in the 1st quarter. Great West Life Assurance Co. Can now owns 34,194 shares of the industrial products company’s stock valued at $1,746,000 after acquiring an additional 2,738 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Proto Labs by 5.3% in the 1st quarter. Bank of New York Mellon Corp now owns 345,561 shares of the industrial products company’s stock valued at $17,657,000 after acquiring an additional 17,316 shares during the last quarter. Finally, Comerica Bank increased its holdings in shares of Proto Labs by 4.6% in the 1st quarter. Comerica Bank now owns 27,133 shares of the industrial products company’s stock valued at $1,586,000 after acquiring an additional 1,184 shares during the last quarter.

Proto Labs Company Profile

Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.

Get a free copy of the Zacks research report on Proto Labs (PRLB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Proto Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs Inc. and related companies with MarketBeat.com's FREE daily email newsletter.